Saskatoon researchers in 'very early stages' of animal testing hantavirus vaccine

Researchers at the University of Saskatchewan's VIDO say they are in the very early stages of preclinical animal testing for a hantavirus vaccine. The team said rollout is still years away, indicating the program is still at a nascent development stage with limited near-term commercial impact.

Analysis

Researchers at the University of Saskatchewan's VIDO say they are in the very early stages of preclinical animal testing for a hantavirus vaccine. The team said rollout is still years away, indicating the program is still at a nascent development stage with limited near-term commercial impact.